Cited by CrossRef (25)
- Maurits F. J. M. Vissers, Jules A. A. C. Heuberger, Geert Jan Groeneveld. Targeting for Success: Demonstrating Proof-of-Concept with Mechanistic Early Phase Clinical Pharmacology Studies for Disease-Modification in Neurodegenerative Disorders. IJMS 2021;22:1615
- Jinan Xu, Xingjiang Jin, Zuting Ye, Dandan Wang, Hang Zhao, Zhiqian Tong. Opposite Roles of Co-enzyme Q10 and Formaldehyde in Neurodegenerative Diseases. Am J Alzheimers Dis Other Demen 2022;37:153331752211432
- Beatriz Sequeira-Antunes, Hugo Alexandre Ferreira. Urinary Biomarkers and Point-of-Care Urinalysis Devices for Early Diagnosis and Management of Disease: A Review. Biomedicines 2023;11:1051
- Alicia B. Pomilio, Arturo A. Vitale, Alberto J. Lazarowski. Uncommon Noninvasive Biomarkers for the Evaluation and Monitoring of the Etiopathogenesis of Alzheimer's Disease. CPD 2022;28:1152
- Augoustos Tsamourgelis, Peter Swann, Leonidas Chouliaras, John T. O’Brien. From protein biomarkers to proteomics in dementia with Lewy Bodies. Ageing Research Reviews 2023;83:101771
- Andri Hardiansyah, Gardin Muhammad Andika Saputra, Hikmat Hikmat, Yuniar Elfira Kusfarida, Ni Luh Wulan Septiani, Ahmad Randy, Angga Hermawan, Brian Yuliarto, Ting‐Yu Liu, Tetsuya Kida. Electrochemical evaluation of magnetic reduced graphene oxide nanosheet‐modified glassy carbon electrode on dopamine electrochemical sensor for Parkinson's diagnostic application. J Chinese Chemical Soc 2023;70:1665
- Yuqing Liu, Ziyun Shen, Chenyang Zhao, Youhe Gao. Urine proteomic analysis of the rat e-cigarette model. 2023;11:e16041
- Zita Kruize, Isa van Campen, Lisa Vermunt, Olaf Geerse, Josephine Stoffels, Charlotte Teunissen, Lia van Zuylen. Delirium pathophysiology in cancer: neurofilament light chain biomarker – narrative review. BMJ Support Palliat Care 2024:spcare-2024-004781
- Xuyin Ding, Yecheng Zhang, Yue Zhang, Xufa Ding, Hanxin Zhang, Tian Cao, Zhi-bei Qu, Jing Ren, Lei Li, Zhijun Guo, Feng Xu, Qi-Xian Wang, Xing Wu, Guoyue Shi, Hossam Haick, Min Zhang. Modular Assembly of MXene Frameworks for Noninvasive Disease Diagnosis via Urinary Volatiles. ACS Nano 2022;16:17376
- Kawin Khachornsakkul, Anongnat Tiangtrong, Araya Suwannasom, Wuttichai Sangkharoek, Opor Jamjumrus, Wijitar Dungchai. Distance-based β-amyloid protein detection on PADs for the scanning and subsequent follow-up of Alzheimer's disease in human urine samples. Analyst 2022;147:695
- Arnoldo Armenta-Castro, Mónica T. Núñez-Soto, Kassandra O. Rodriguez-Aguillón, Alberto Aguayo-Acosta, Mariel Araceli Oyervides-Muñoz, Shane A. Snyder, Damià Barceló, Jayaprakash Saththasivam, Jenny Lawler, Juan Eduardo Sosa-Hernández, Roberto Parra-Saldívar. Urine biomarkers for Alzheimer's disease: A new opportunity for wastewater-based epidemiology?. Environment International 2024;184:108462
- Rui-Xian Li, Ya-Hui Ma, Lan Tan, Jin-Tai Yu. Prospective biomarkers of Alzheimer’s disease: A systematic review and meta-analysis. Ageing Research Reviews 2022;81:101699
- Ka Young Kim, Ki Young Shin, Keun-A Chang. Brain-Derived Exosomal Proteins as Effective Biomarkers for Alzheimer’s Disease: A Systematic Review and Meta-Analysis. Biomolecules 2021;11:980
- Xun Gong, Hantao Zhang, Xiaoyan Liu, Yi Liu, Junlin Liu, Funmilayo O. Fapohunda, Peng Lü, Kun Wang, Min Tang. Is liquid biopsy mature enough for the diagnosis of Alzheimer’s disease?. Front. Aging Neurosci. 2022;14
- Yuye Wang, Yu Sun, Yu Wang, Shuhong Jia, Yanan Qiao, Zhi Zhou, Wen Shao, Xiangfei Zhang, Jing Guo, Xincheng Song, Xiaoqian Niu, Dantao Peng. Urine metabolomics phenotyping and urinary biomarker exploratory in mild cognitive impairment and Alzheimer’s disease. Front. Aging Neurosci. 2023;15
- Zhiqi Song, Yajin Qu, Yanfeng Xu, Ling Zhang, Li Zhou, Yunlin Han, Wenjie Zhao, Pin Yu, Yu Zhang, Xianglei Li, Chuan Qin. Microarray microRNA profiling of urinary exosomes in a 5XFAD mouse model of Alzheimer’s disease. Anim Models and Exp Med 2021;4:233
- Da Hae Jung, Gowoon Son, Oh-Hoon Kwon, Keun-A Chang, Cheil Moon. Non-Invasive Nasal Discharge Fluid and Other Body Fluid Biomarkers in Alzheimer’s Disease. Pharmaceutics 2022;14:1532
- Banabihari Giri, Marissa Seamon, Aditi Banerjee, Sneha Chauhan, Sharad Purohit, John Morgan, Babak Baban, Chandramohan Wakade. Emerging urinary alpha-synuclein and miRNA biomarkers in Parkinson’s disease. Metab Brain Dis 2022;37:1687
- Konstantin Kohlhase, Franziska Frank, Christian Wilmes, Kimberly Koerbel, Martin A. Schaller‐Paule, Martha Miles, Christoph Betz, Helmuth Steinmetz, Christian Foerch. Brain‐specific biomarkers in urine as a non‐invasive approach to monitor neuronal and glial damage. Euro J of Neurology 2023;30:729
- Nazia Saiyed, Ali Yilmaz, Sangeetha Vishweswariah, Amit K. Maiti, Ilyas Ustun, Sarah Bartolone, Travonia Brown-Hughes, Roland J. Thorpe, Tammy Osentoski, Stacey Ruff, Amita Pai, Michael Maddens, Khaled Imam, Stewart F. Graham. Urinary Cytokines as Potential Biomarkers of Mild Cognitive Impairment and Alzheimer’s Disease: A Pilot Study. ADR 2023;7:649
- Yuye Wang, Yu Sun, Yu Wang, Shuhong Jia, Yanan Qiao, Zhi Zhou, Wen Shao, Xiangfei Zhang, Jing Guo, Bin Zhang, Xiaoqian Niu, Yi Wang, Dantao Peng. Identification of novel diagnostic panel for mild cognitive impairment and Alzheimer’s disease: findings based on urine proteomics and machine learning. Alz Res Therapy 2023;15
- Vaibhav Sharma, Fredrik Nikolajeff, Saroj Kumar. Employing nanoparticle tracking analysis of salivary neuronal exosomes for early detection of neurodegenerative diseases. Transl Neurodegener 2023;12
- Javier Frontiñán-Rubio, Yoana Rabanal-Ruiz, Juan R. Peinado, Tomas Deierborg. Editorial: Present and future of biological fluid biomarkers in dementia. Front. Aging Neurosci. 2023;15
- Mingming Xu, Arthur Yang, Jun Xia, Junhong Jiang, Chun-Feng Liu, Zhenyu Ye, Junfeng Ma, Shuang Yang. Protein glycosylation in urine as a biomarker of diseases. Translational Research 2023;253:95
- Chen Dong, Chandrashekhar Honrao, Leonardo O. Rodrigues, Josephine Wolf, Keri B. Sheehan, Matthew Surface, Roy N. Alcalay, Elizabeth M. O’Day. Plasma Metabolite Signature Classifies Male LRRK2 Parkinson’s Disease Patients. Metabolites 2022;12:149